Title
Cryptosporidium infection of human intestinal epithelial cells increases expression of osteoprotegerin: A novel mechanism for evasion of host defenses
Date Issued
15 March 2008
Access level
open access
Resource Type
journal article
Author(s)
Castellanos-Gonzalez A.
Yancey L.S.
Wang H.C.
Pantenburg B.
Liscum K.R.
Lewis D.E.
University of Texas Medical Branch, Galveston
Publisher(s)
Oxford University Press
Abstract
Cryptosporidium parasites are pathogens of human intestinal epithelial cells. To determine which genes are regulated during early infection, human ileal mucosa cultured as explants was infected with C. parvum or C. hominis, and gene expression was analyzed by microarray. The gene for osteoprotegerin (OPG) was up-regulated by both parasites. OPG mRNA was also significantly increased in biopsy specimens obtained from a volunteer experimentally infected with C. meleagridis, compared with levels in a prechallenge biopsy specimen. After in vitro infection of HCT-8 cells, there was an early peak in production of OPG mRNA protein. Treatment of infected cells with the OPG ligand tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced epithelial cell apoptosis and reduced parasite numbers, and recombinant OPG blocked these effects. These results suggest a novel TRAIL-mediated pathway for elimination of Cryptosporidium infection and a role for OPG in modulating this host response. © 2008 by the Infectious Diseases Society of America. All rights reserved.
Start page
916
End page
923
Volume
197
Issue
6
Language
English
OCDE Knowledge area
Genética humana Bioquímica, Biología molecular
Scopus EID
2-s2.0-40949124848
PubMed ID
Source
Journal of Infectious Diseases
ISSN of the container
00221899
Sponsor(s)
Received 12 June 2007; accepted 5 September 2007; electronically published 20 February 2008. Potential conflicts of interest: none reported. Presented in part: Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, 12–16 November 2006 (poster 263). Financial support: National Institutes of Health (grant R01 AI041735I). Reprints or correspondence: Dr. A. Clinton White, Director, Infectious Disease Div., Dept. of Internal Medicine, University of Texas Medical Branch, 301 University Blvd., Rt. 0435, Galveston, TX 77555-0435 (acwhite@utmb.edu).
Sources of information: Directorio de Producción Científica Scopus